RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Clinical trials for RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES trials appear
Sign up with your email to follow new studies for RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot cancer treatment trial seeks to reprogram immune system from within
Disease control Not yet recruitingThis early-stage study is testing the safety of an experimental therapy called DIT101 for adults whose blood cancers have returned or not responded to standard treatments. DIT101 is a one-time infusion designed to instruct the body's own immune system to create cancer-fighting ce…
Matched conditions: RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: Tcelltech Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for tough blood cancers: early trial tests BT02
Disease control Not yet recruitingThis early-stage study aims to test the safety and early effectiveness of an investigational drug called BT02 for adults with blood cancers that have returned or not responded to previous treatments. Participants will receive BT02 through an IV every few weeks for up to two years…
Matched conditions: RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Biotroy Therapeutics • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC